Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1990 Dec;45(12):924–929. doi: 10.1136/thx.45.12.924

Analysis of bronchial reactivity in epidemiological studies.

M J Abramson 1, N A Saunders 1, M J Hensley 1
PMCID: PMC462839  PMID: 2281424

Abstract

The measurement of bronchial reactivity in epidemiological studies has the advantage of quantifying an objective physiological feature of asthma. Bronchial reactivity was developed in a clinical setting and has been conventionally expressed as the dose of agonist producing a 20% fall in FEV1 (PD20). As PD20 can be estimated for less than 20% of subjects in general community surveys with the doses of agonist that are usually given, data from most subjects must be censored. Thus PD20 alone is a poor index of bronchial reactivity for epidemiological studies. Data from 809 aluminium smelter workers were used to evaluate alternative methods of analysing bronchial reactivity. Dose-response relationships were analysed by four methods: (1) PD20 by the conventional method of interpolating the dose on a logarithmic scale between the last two measurements of FEV1; (2) PD20 (with allowance for extrapolation), estimated by fitting an exponential curve to the dose-response data; (3) the linear regression slope between dose and FEV1 when significant; (4) the dose-response slope obtained in all subjects as the % change in FEV1 from baseline in response to total dose. When each of these measures was related to symptoms, diagnosis, and treatment of asthma, all differentiated between "asthmatic" and "non-asthmatic" subjects. The dose-response slope (method 4) had the advantages of simplicity and no censored data, and was shown to be clinically relevant. It is suggested that the dose-response slope should be used for the analysis of bronchial reactivity in epidemiological studies.

Full text

PDF
924

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asher M. I., Pattemore P. K., Harrison A. C., Mitchell E. A., Rea H. H., Stewart A. W., Woolcock A. J. International comparison of the prevalence of asthma symptoms and bronchial hyperresponsiveness. Am Rev Respir Dis. 1988 Sep;138(3):524–529. doi: 10.1164/ajrccm/138.3.524. [DOI] [PubMed] [Google Scholar]
  2. Bellia V., Rizzo A., Amoroso S., Mirabella A., Bonsignore G. Analysis of dose-response curves in the detection of bronchial hyperreactivity. Respiration. 1983;44(1):10–18. doi: 10.1159/000194522. [DOI] [PubMed] [Google Scholar]
  3. Britton J. R., Burney P. G., Chinn S., Papacosta A. O., Tattersfield A. E. The relation between change in airway reactivity and change in respiratory symptoms and medication in a community study. Am Rev Respir Dis. 1988 Sep;138(3):530–534. doi: 10.1164/ajrccm/138.3.530. [DOI] [PubMed] [Google Scholar]
  4. Britton W. J., Woolcock A. J., Peat J. K., Sedgwick C. J., Lloyd D. M., Leeder S. R. Prevalence of bronchial hyperresponsiveness in children: the relationship between asthma and skin reactivity to allergens in two communities. Int J Epidemiol. 1986 Jun;15(2):202–209. doi: 10.1093/ije/15.2.202. [DOI] [PubMed] [Google Scholar]
  5. Burney P. G., Britton J. R., Chinn S., Tattersfield A. E., Papacosta A. O., Kelson M. C., Anderson F., Corfield D. R. Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax. 1987 Jan;42(1):38–44. doi: 10.1136/thx.42.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chai H., Farr R. S., Froehlich L. A., Mathison D. A., McLean J. A., Rosenthal R. R., Sheffer A. L., Spector S. L., Townley R. G. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol. 1975 Oct;56(4):323–327. doi: 10.1016/0091-6749(75)90107-4. [DOI] [PubMed] [Google Scholar]
  7. Chinn S., Britton J. R., Burney P. G., Tattersfield A. E., Papacosta A. O. Estimation and repeatability of the response to inhaled histamine in a community survey. Thorax. 1987 Jan;42(1):45–52. doi: 10.1136/thx.42.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cockcroft D. W., Berscheid B. A. Slope of the dose-response curve: usefulness in assessing bronchial responses to inhaled histamine. Thorax. 1983 Jan;38(1):55–61. doi: 10.1136/thx.38.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dowse G. K., Smith D., Turner K. J., Alpers M. P. Prevalence and features of asthma in a sample survey of urban Goroka, Papua New Guinea. Clin Allergy. 1985 Sep;15(5):429–438. doi: 10.1111/j.1365-2222.1985.tb02292.x. [DOI] [PubMed] [Google Scholar]
  10. Enterline P. E. Estimating health risks in studies of the health effects of asbestos. Am Rev Respir Dis. 1976 Feb;113(2):175–180. doi: 10.1164/arrd.1976.113.2.175. [DOI] [PubMed] [Google Scholar]
  11. Malo J. L., Cartier A., Pineau L., Gagnon G., Martin R. R. Slope of the dose-response curve to inhaled histamine and methacholine and PC20 in subjects with symptoms of airway hyperexcitability and in normal subjects. Am Rev Respir Dis. 1985 Sep;132(3):644–647. doi: 10.1164/arrd.1985.132.3.644. [DOI] [PubMed] [Google Scholar]
  12. Mortagy A. K., Howell J. B., Waters W. E. Respiratory symptoms and bronchial reactivity: identification of a syndrome and its relation to asthma. Br Med J (Clin Res Ed) 1986 Aug 30;293(6546):525–529. doi: 10.1136/bmj.293.6546.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. O'Connor G., Sparrow D., Taylor D., Segal M., Weiss S. Analysis of dose-response curves to methacholine. An approach suitable for population studies. Am Rev Respir Dis. 1987 Dec;136(6):1412–1417. doi: 10.1164/ajrccm/136.6.1412. [DOI] [PubMed] [Google Scholar]
  14. Salome C. M., Peat J. K., Britton W. J., Woolcock A. J. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy. 1987 Jul;17(4):271–281. doi: 10.1111/j.1365-2222.1987.tb02015.x. [DOI] [PubMed] [Google Scholar]
  15. Sears M. R., Jones D. T., Holdaway M. D., Hewitt C. J., Flannery E. M., Herbison G. P., Silva P. A. Prevalence of bronchial reactivity to inhaled methacholine in New Zealand children. Thorax. 1986 Apr;41(4):283–289. doi: 10.1136/thx.41.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Standardization of spirometry--1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis. 1987 Nov;136(5):1285–1298. doi: 10.1164/ajrccm/136.5.1285. [DOI] [PubMed] [Google Scholar]
  17. Woolcock A. J., Peat J. K., Salome C. M., Yan K., Anderson S. D., Schoeffel R. E., McCowage G., Killalea T. Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population. Thorax. 1987 May;42(5):361–368. doi: 10.1136/thx.42.5.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Woolcock A. J., Salome C. M., Yan K. The shape of the dose-response curve to histamine in asthmatic and normal subjects. Am Rev Respir Dis. 1984 Jul;130(1):71–75. doi: 10.1164/arrd.1984.130.1.71. [DOI] [PubMed] [Google Scholar]
  19. Yan K., Salome C., Woolcock A. J. Rapid method for measurement of bronchial responsiveness. Thorax. 1983 Oct;38(10):760–765. doi: 10.1136/thx.38.10.760. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES